Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
55 , 61376148 (2012) Lau, J
Clinical trials have shown they slow the progression of several chronic diseases, including cardiovascular, kidney, and fatty liver diseases
It is important to note that randomized trials typically involve a highly selective group of individuals who do not accurately reflect the general population with T2DM
FOXO4 Peptide (FOXO4-DRI) Synonyms: FOXO4-DRI, FOXO4 inhibitory peptide, FOXO4 decoy peptide CAS Number: N/A Peptide Classification: Synthetic modified peptide
Access, Cost, and Supply Considerations Wegovy carries a list price of approximately $1,349 per month in the United States as of early 2025
We encourage all patients to discuss current regulatory status with our providers during consultation
US$ 28.55
US$ 20.96
US$ 26.32
US$ 24.55
US$ 26.05
US$ 27.39
